☰

Krista M. La Perle, Ph.D. - Publications

Affiliations: 
2002 Ohio State University, Columbus, Columbus, OH 
Area:
Pathology, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bowman RL, Hennessey RC, Weiss TJ, Tallman DA, Crawford ER, Murphy BM, Webb A, Zhang S, La Perle KM, Burd CJ, Levine RL, Shain AH, Burd CE. UVB mutagenesis differs in - and -mutant mouse models of melanoma. Life Science Alliance. 4. PMID 34210801 DOI: 10.26508/lsa.202101135  0.367
2020 Saji M, Kim CS, Wang C, Zhang X, Khanal T, Coombes K, La Perle K, Cheng SY, Tsichlis PN, Ringel MD. Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. Scientific Reports. 10: 18316. PMID 33110146 DOI: 10.1038/s41598-020-75529-0  0.485
2019 Knippler CM, Saji M, Rajan N, Porter K, La Perle K, Ringel MD. MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition. Endocrine-Related Cancer. PMID 31146260 DOI: 10.1530/ERC-19-0188  0.374
2018 Huk D, Ashtekar A, Magner A, La Perle K, Kirschner LS. Deletion of Rap1b, but not Rap1a or Epac1, reduces PKA-mediated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. PMID 29882482 DOI: 10.1089/thy.2017.0528  0.358
2018 Relation T, Yi T, Guess AJ, La Perle K, Otsuru S, Hasgur S, Dominici M, Breuer C, Horwitz EM. Intratumoral Delivery of Interferon γ-secreting MSCs Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo. Stem Cells (Dayton, Ohio). PMID 29430789 DOI: 10.1002/Stem.2801  0.384
2017 Tsai YT, Lakshmanan A, Lehman A, Harrington BK, Lucas FM, Tran M, Sass EJ, Long M, Flechtner AD, Jaynes F, La Perle K, Coppola V, Lozanski G, Muthusamy N, Byrd JC, et al. BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia. Blood Advances. 1: 2147-2160. PMID 29296862 DOI: 10.1182/Bloodadvances.2017006593  0.347
2017 Ashtekar A, Huk D, Magner A, La Perle K, Zhang X, Piruat J, Lopez-Barneo J, Jhiang S, Kirschner L. Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocrine-Related Cancer. PMID 28928232 DOI: 10.1530/Erc-17-0229  0.653
2017 Comiskey DF, Jacob AG, Sanford BL, Montes M, Goodwin AK, Steiner H, Matsa E, Tapia-Santos AS, Bebee TW, Grieves J, La Perle K, Boyaka P, Chandler DS. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene. PMID 28892044 DOI: 10.1038/Onc.2017.282  0.329
2017 Wang C, Saji M, Justiniano SE, Yusof AM, Zhang X, Yu L, Fernández S, Wakely P, La Perle K, Nakanishi H, Pohlman N, Ringel MD. RCAN1-4 is a thyroid cancer growth and metastasis suppressor. Jci Insight. 2: e90651. PMID 28289712 DOI: 10.1172/jci.insight.90651  0.483
2016 Karras JR, Schrock MS, Batar B, Zhang J, La Perle K, Druck T, Huebner K. Fhit loss-associated initiation and progression of neoplasia in vitro. Cancer Science. PMID 27513973 DOI: 10.1111/Cas.13032  0.331
2015 Caserta E, Egriboz O, Wang H, Martin C, Koivisto C, Pecót T, Kladney RD, Shen C, Shim KS, Pham T, Karikomi MK, Mauntel MJ, Majumder S, Cuitino MC, Tang X, ... ... La Perle KM, et al. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes & Development. 29: 1707-20. PMID 26302789 DOI: 10.1101/Gad.262568.115  0.396
2015 Berman-Booty LD, Thomas-Ahner JM, Bolon B, Oglesbee MJ, Clinton SK, Kulp SK, Chen CS, La Perle KM. Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice. Toxicologic Pathology. 43: 186-97. PMID 24742627 DOI: 10.1177/0192623314531351  0.408
2014 Pringle DR, Vasko VV, Yu L, Manchanda PK, Lee AA, Zhang X, Kirschner JM, Parlow AF, Saji M, Jarjoura D, Ringel MD, La Perle KM, Kirschner LS. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice. The Journal of Clinical Endocrinology and Metabolism. 99: E804-12. PMID 24512487 DOI: 10.1210/jc.2013-3101  0.379
2014 De Lorenzo MS, Chen W, Baljinnyam E, Carlini MJ, La Perle K, Bishop SP, Wagner TE, Rabson AB, Vatner DE, Puricelli LI, Vatner SF. 'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'. Aging Cell. 13: 102-10. PMID 23957304 DOI: 10.1111/Acel.12152  0.408
2013 La Perle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy RS, Wakely PE, Lehman A, Jarjoura D, Jhiang SM. Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid : Official Journal of the American Thyroid Association. 23: 1029-36. PMID 23441638 DOI: 10.1089/Thy.2012.0571  0.734
2013 Manchanda PK, Jones GN, Lee AA, Pringle DR, Zhang M, Yu L, La Perle KM, Kirschner LS. Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors. Oncogene. 32: 3491-9. PMID 23045281 DOI: 10.1038/onc.2012.374  0.365
2012 Rosas LE, Grieves JL, Zaraspe K, La Perle KM, Fu H, McCarty DM. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2098-110. PMID 22990674 DOI: 10.1038/Mt.2012.197  0.366
2012 Pringle DR, Yin Z, Lee AA, Manchanda PK, Yu L, Parlow AF, Jarjoura D, La Perle KM, Kirschner LS. Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer. Endocrine-Related Cancer. 19: 435-46. PMID 22514108 DOI: 10.1530/ERC-11-0306  0.477
2011 Mundy-Bosse BL, Lesinski GB, Jaime-Ramirez AC, Benninger K, Khan M, Kuppusamy P, Guenterberg K, Kondadasula SV, Chaudhury AR, La Perle KM, Kreiner M, Young G, Guttridge DC, Carson WE. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Research. 71: 5101-10. PMID 21680779 DOI: 10.1158/0008-5472.CAN-10-2670  0.313
2011 Saji M, Narahara K, McCarty SK, Vasko VV, La Perle KM, Porter K, Jarjoura D, Lu C, Cheng SY, Ringel MD. Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene. 30: 4307-15. PMID 21532616 DOI: 10.1038/Onc.2011.136  0.514
2010 Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Wang D, Sadee W, La Perle K, Stromberg P, et al. Allele-specific tumor spectrum in pten knockin mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 5142-7. PMID 20194734 DOI: 10.1073/Pnas.0912524107  0.351
2007 Brentjens RJ, Santos E, Nikhamin Y, Yeh R, Matsushita M, La Perle K, Quintás-Cardama A, Larson SM, Sadelain M. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5426-35. PMID 17855649 DOI: 10.1158/1078-0432.Ccr-07-0674  0.321
2007 Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell. 11: 245-58. PMID 17349582 DOI: 10.1016/J.Ccr.2007.01.015  0.376
2004 Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, La Perle K, Vaughan CJ, O'Hagan A, Bennett KR, Meyer BJ, Legius E, Karttunen M, Norio R, Kaariainen H, et al. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proceedings of the National Academy of Sciences of the United States of America. 101: 14222-7. PMID 15371594 DOI: 10.1073/Pnas.0405535101  0.304
2003 La Perle KM, Blomme EA, Capen CC, Jhiang SM. Effect of exogenous human sodium iodide symporter expression on growth of MATLyLu cells. Thyroid : Official Journal of the American Thyroid Association. 13: 133-40. PMID 12699587 DOI: 10.1089/105072503321319431  0.705
2002 La Perle KM, Blomme EA, Sagartz JE, Capen CC. Epididymal cribriform hyperplasia with nuclear atypia in p53 homozygous knockout mice on a mixed 129/Sv-FVB/N background. Comparative Medicine. 52: 568-71. PMID 12540173  0.32
2002 Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML, Jhiang SM. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation. Oncogene. 21: 8166-72. PMID 12444552 DOI: 10.1038/Sj.Onc.1205938  0.508
2002 La Perle KM, Shen D, Buckwalter TL, Williams B, Haynam A, Hinkle G, Pozderac R, Capen CC, Jhiang SM. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. The Prostate. 50: 170-8. PMID 11813209 DOI: 10.1002/Pros.10046  0.557
2000 La Perle KM, Jhiang SM, Capen CC. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. The American Journal of Pathology. 157: 671-7. PMID 10934169 DOI: 10.1016/S0002-9440(10)64577-4  0.667
Show low-probability matches.